The Antibody Society has partnered with numerous conference organizers, including Informa Connect, Cambridge Healthtech Institute, Hanson Wade, and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
We have also partnered with Schrödinger, and are pleased to offer 10% discounts to our members for their online course, Introduction to Computational Antibody Engineering.
To access the discount codes, please log into website and navigate to the Member discount codes page in the Members Only area.
Schrödinger’s online course, Introduction to Computational Antibody Engineering, will show how industry-leading computational molecular modeling solutions are used to aid in antibody discovery and design and how to incorporate these computational approaches into your research project. This course will also provide a chance to work hands-on with Schrödinger’s BioLuminate software.
Upcoming 2024 session dates:
- April 2, 2024 – May 8, 2024
- April 16, 2024 – May 22, 2024
- April 30, 2024 – June 5, 2024
The Antibody Society members save 10% off your booking – log into the Members Only area or contact membership@antibodysociety.org for the discount code.
May 2024
6th Annual Cell Engager Summit is back | May 21 – 23, 2024
Advancing the Development of Novel Targets, Safe, & Effective Multi-Specific Immune Cell Engagers for Solid & Liquid Tumors in the Clinic.
With a whopping 7 approvals in the last two years, the field is alive with positive clinical read outs and the drive to get more life changing cell engager therapeutics to patients in indications of huge unmet need.
The 6th Cell Engager Therapeutics Summit is back once again to meet the needs of the community, focused on reaching new indications by expanding the target space and focusing our content to novel targets as well as continuing the push to focus on the translational challenges of developing cell engager therapies for solid and liquid tumours.
Dates: May 21 – 23, 2024
Location: Embassy Suites by Hilton Boston at Logan Airport, Boston, MA
Event Program: https://ter.li/vjsuhg
Join 100+ of your colleagues from JNJ, Astellas, Amgen, CDRLife, Regeneron, Immunocore, Crossbow Therapeutics and AstraZeneca in discovery and translational sciences, learn from clinical case studies to back translate, improve engineering by tuning affinity via adapting engager format and mitigating cytokine release syndrome. This is your one stop shop for all of the must have content dedicated to all engagers such as T-cell engagers, BiTe’s, gamma delta engagers and NK engagers.
As we look to prioritize the next generation intracellular targets, how you go about validating, discovering, and creating the next therapies to target them, the power of cell engager technology is clear. Overcome your key challenges in developing cell engagers across three days of highly focused content – don’t miss out!
Download the agenda here: https://ter.li/vjsuhg
Register your place here: https://ter.li/xfju0q and take advantage of group discounts of up to 20% when sending your team of three or more!
The Antibody Society members save 10% off the conference registration – contact membership@antibodysociety.org or visit the Members Only section of the website to find the discount code.
Registration is open!
Why Attend the JAX Workshop Series?
- Discover the Role of Humanized Mouse Models in Drug Development
- Explore the ground-breaking advancements in humanized models that are transforming the field of drug discovery.
- Position Yourself at the Forefront of Translational Pharmacology
- Join JAX in exploring the latest trends, technologies, and advancements in translational pharmacology. Discover how our cutting-edge platforms and services are shaping the future of pharmaceutical research. Get ahead of the curve by staying at the forefront of translational models for drug development.
- Connect With Leaders in the Field
- Network with industry leaders, researchers, and professionals in a collaborative environment. Forge partnerships that drive progress and elevate your organization’s impact. Engage with thought leaders and experts who will share their knowledge and experiences in translational pharmacology.
Celebrating 20 years!
The PEGS Boston Summit brings together leading experts at the forefront of biologics innovation, providing insights into the latest technologies, research, and advancements in drug development, protein and antibody engineering, immunotherapy, immunogenicity, expression platforms, multispecific antibodies, machine learning and AI in biologics, and more.
PEGS Boston features main conference sessions as well as deep dive training seminars and topic-focused short courses. The PEGS Boston Summit is your number one resource for protein engineering updates and is the conference to attend in 2024 to network, collaborate, and learn from the industry’s best.
Registration is open!
Antibody Society members save 20% off the conference registration– contact membership@antibodysociety.org or visit the Members Only section of the website to find the discount code.
June 2024
15 years after the first AIRR-seq sequencing, what have we learned in the basic and biomedical research fields? What is next?
AIRR Community Meeting VII: Learnings and Perspectives that will be held at the University of Porto in Porto, Portugal from June 3-6, 2024. Registration will open at the end of January. Learn more here.
Antibody Engineering & Therapeutics Europe 2024
Hybrid 4 – 6 June 2024 | London ExCel Platinum Suite
Are you seeking the latest antibody and protein research updates? Do you want to hear from pioneers who are shaping the field?
Be part of the #1 European antibody engineering conference from 4 – 6 June 2024. Created in conjunction with The Antibody Society, this year’s conference is coming to London – a true hub of the antibody community. Boasting 9 topic streams covering the need to know updates in industry, you will dive into:
- Fc Engineering
- Novel Approaches to Antibody Discovery
- Challenges in Discovery & Optimization of Multispecific Antibodies
- Agonist Antibodies
- Conditionally Active Biotherapeutics
- Emerging Modalities: ADCs, Degraders and Beyond
- Computational Approaches to Antibody Discovery and Optimization
- Co-Stimulatory Antibodies and Combination Approaches in Oncology
- Antibody Theranostics
Download the agenda here
There’s no better place to get the most critical updates that will help you to accelerate your path to market. Don’t miss your opportunity to be part of the discussions shaping the industry.
Antibody Society members save 15% off the conference registration– contact membership@antibodysociety.org or visit the Members Only section of the website to find the discount code.
With a storm of collaborations and novel innovations happening, all eyes are turning towards the APAC region for the next best thing when it comes to antibody-drug conjugate development. The 3rd World ADC Asia (June 25-27, 2024 | Incheon, South Korea) is back to unite the growing community of Asian-based drug developers.
The 3-day agenda has been designed to allow insightful discussions into your most pressing challenges, novel payloads, identifying unique targets, stable linker chemistries, working through manufacturing and regulatory hurdles, and more to boost ADC development and innovation.
Take a look at the full agenda here.
With a stellar lineup of 25+ industry-leading speakers from within Asia, here is a snapshot of who you could meet this June:
- Jinwon Jung, Senior Director, ABL Bio
- Dohyun Nam, Chairman, Aimed Bio
- Ziping Wei, Chief Executive Officer, Bliss Biopharma
- Yasuyuki Kaneta, Senior Director, Daiichi Sankyo
- Masayuki Miyano, Principal Scientist, Eisai
- Jun Ge, Executive Director, Head of China Clinical Development, Gilead
- Tse Wen Chang, Founder & Chairman, Immunwork
- Sun-Hwa Lee, Chief Scientific Officer, Novelty Nobility
- Heidi Wang, Chief Executive Officer, OBI Pharma
- Hyun Yong Cho, Chief Scientific Officer, PinotBio
See the full speaker faculty and session details here.
We hope you can join us at this must-attend event for the ADC Community based in the APAC region where the East will meet the West to propel your ADC development further than ever before.
Antibody Society members save 10% off the conference registration– contact membership@antibodysociety.org or visit the Members Only section of the website to find the discount code.
12th Antibody Industrial Symposium (AIS2024) | June 20-21, 2024 Montpellier, France.
Registration: https://aiscongress.com/register.php
The 12th Antibody Industrial Symposium AIS2024 jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector, will be held on June 20-21 2024, in Montpellier, France. The AIS2024 is the ideal conference for scientists, industrials, clinicians, and policy makers to exchange about therapeutic antibodies and more!
This year’s 2-days-programme is organized into several tracks covering the hot topics in antibody, recombinant proteins, CART cells and other biopharmaceuticals research and development. Moreover, the program will allow opportunities for one-to-one meetings, companies to showcase their new products and technologies virtually as well as dedicated time for business partnering.
Call for Abstracts: Submit your Abstract to give a Pitch presentation or present your Poster at the AIS2024.
Abstract submission deadline is April 12th, 2024! View guideline HERE
September 2024
15th World Bispecific Summit | September 3-5, 2024
Radically Optimize Bi, Tri & Multispecific Antibodies to Enhance Target Discovery, Mechanistic Diversity & Clinical Translation to Maximize the Therapeutic Index & Enhance Combinations.
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, highlighting biopharma’s continued investment within bispecific therapeutics.
As we look to the future of bispecific drugs and focus on novel formats and exploring new mechanisms to differentiate from the crowd, the 15th World Bispecific Summit continues to be the industry’s one-stop-shop for all your strategic needs within bi, tri or multi-specifics or even bispecific ADCs or BiTEs.
Dates: September 3-5, 2024
Location: The Royal Sonesta Boston, 40 Edwin H Land Blvd, Cambridge, MA 02142, United States
Click here to download the event program:
Drug developers across discovery, preclinical and clinical development are joining forces once more to create an improved foothold in this exciting area of drug discovery and bring better and more efficacious bispecific drugs to patients across different disease indications.
Given the reach bispecific drugs can have, the hunt is on for novel targets that can transform the lives of patients, whether it’s new targets and combinations to improve the safety profile for haematological malignancies, overcoming the immunosuppressive microenvironment within solid tumors, or switching the immune system off in autoimmune disease.
Moving towards more personalized medicine, profiling bispecific candidates preclinically to ensure the developability has never been more important. Although time consuming, the benefits in the reduction of the risk and spend is huge in getting candidates into the clinic. Join this meeting to hear novel ideas and concepts, preclinical data, and clinical lessons to enhance the developability of your bispecific drug.
Click here to download the agenda
Click here and register your place. Take advantage of group discounts of up to 20% when sending your team of three or more!